Under-utilization of statins among people with HIV who were aged 40 years or older
Journal
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Journal Volume
57
Journal Issue
1
Date Issued
2024-02
Author(s)
Wu, Pei-Ying
Luo, Yu-Zhen
Chang, Hsi-Yen
Chen, Ling-Ya
Chen, Yi-Ting
Abstract
From June 2022 to April 2023, 1629 HIV-positive participants were assessed for the risk of atherosclerotic cardiovascular disease (ASCVD). The 10-year ASCVD risk of <5 %, 5 % to <7.5 %, ≥7.5 % to <20 % and ≥20 % were 59.9 %, 14.4 %, 20.7 % and 5.0 %, respectively; 440 (27.0 %) participants met the criteria for statin therapy, but only 171 (38.8 %) were prescribed statins.
Subjects
Atherosclerotic cardiovascular disease; Diabetes mellitus; Dyslipidemia; Lipid-lowering agent; Major adverse cardiovascular event; Non-communicable disease
Type
journal article